MERLO, FEDERICO
MERLO, FEDERICO
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Heterogeneity of progression-free survival surrogacy by sex in randomized trials testing immunotherapy in non-small cell lung cancer
2025 Pagan, E; Sala, I; Pala, L; Natali, F; Merlo, F; Oriecuia, C; Specchia, C; De Pas, T; Catania, C; Cocorocchio, E; Laszlo, D; Ceresoli, G; Locatelli, M; Cascetta, P; Facella, F; Tinterri, B; Pino, M; Canzian, J; Giaccone, G; Bagnardi, V; Conforti, F
Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugates
2025 Pala, L; Merlo, F; Sala, I; Pagan, E; Oriecuia, C; Specchia, C; Catania, C; Cocorocchio, E; Laszlo, D; Ceresoli, G; Locatelli, M; De Pas, T; Zambelli, A; Cortes, J; Giaccone, G; Moore, K; Bardia, A; Viale, G; Gelber, R; Bagnardi, V; Conforti, F
Why Adjuvant Treatment With a CDK4/6 Inhibitor Should Be Recommended for Women With High-Risk Breast Cancer: Methodologic Considerations on Available Evidence
2025 Conforti, F; Merlo, F; Pala, L; Canzian, J; Tinterri, B; De Pas, T; Locatelli, M; Dickerson, J; Cortes, J; Slamon, D; Gelber, R; Bagnardi, V
| Titolo | Tipologia | Data di pubblicazione | Autori | File |
|---|---|---|---|---|
| Heterogeneity of progression-free survival surrogacy by sex in randomized trials testing immunotherapy in non-small cell lung cancer | 01 - Articolo su rivista | 2025 | Pagan, EleonoraSala, IsabellaNatali, FabrizioMerlo, FedericoBagnardi, Vincenzo + | |
| Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugates | 01 - Articolo su rivista | 2025 | Merlo, FedericoSala, IsabellaPagan, EleonoraZambelli, AlbertoBagnardi, Vincenzo + | |
| Why Adjuvant Treatment With a CDK4/6 Inhibitor Should Be Recommended for Women With High-Risk Breast Cancer: Methodologic Considerations on Available Evidence | 01 - Articolo su rivista | 2025 | Merlo F.Bagnardi V. + |